| Project/Area Number |
23501298
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Tumor diagnosis
|
|---|
| Research Institution | Kagoshima University |
|---|
Principal Investigator |
enokida hideki 鹿児島大学, 医歯(薬)学総合研究科, 准教授 (80347103)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
川上 一盛 鹿児島大学, 医学部・歯学部附属病院, 助教 (00404517)
|
|---|
| Research Collaborator |
YOSHINO HIROFUMI 鹿児島大学, 医歯学総合研究科, 大学院生
HIDAKA HIDEO 鹿児島大学, 医歯学総合研究科, 大学院生
YAMASAKI TAKESHI 鹿児島大学, 医歯学総合研究科, 大学院生
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2011: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | microRNA / 膀胱癌 / 診断マーカー |
|---|
| Outline of Final Research Achievements |
We developed novel urine markers for detecting urothelial carcinoma. Retrospective examination using 100 bladder cancer, 49 healthy volunteers, and 25 urinary tract infection patients revealed that miR-96 and miR-183 could distinguish cancer from benign disease with good sensitivity and specificity. These miRNAs expressions were well correlated with tumor stage and grade as recurrence free survival of non-muscle invasive blader cancer.
As for prospective examination of the out patients with macroscopic hematuria revealed that miR-X was a promising tumor markers with less false posive affected by macroscopic hematuria.
|
